Future studies will focus on confirming a role for IL-23 in the pathogenesis of disease, as well as examining the potential contribution of IL-17, IL-21, and IL-22 to the development of PAH in the context of NK cell deficiency. Here, IL22 is linked to pulmonary arterial hypertension.